Noah Holdings Limited (NOAH) is a Chinese wealth and asset management provider serving Mandarin-speaking high-net-worth investors, listed on the NYSE through American depositary receipts (ADRs). The stock has slid toward the low end of its 52-week range, and investors are weighing whether a rebound toward the roughly $11.30 level reflected in recent analyst price targets is realistic.
The central $11.30 target is calculated from three current, attributable analyst price targets. JPMorgan analyst Peter Zhang lowered the firm's target to $9.70 from $10.50 in September 2026 while keeping a Neutral rating, following an earlier downgrade from Overweight. UBS, which has maintained a Neutral stance, most recently carried a target near $9.20, having trimmed its view through 2026 on legal and provision concerns. Citi, the most bullish of the three, maintained a Buy rating with a $14.90 target established in March 2026, citing a roughly 12% expected dividend yield for 2026.
Those three figures average $11.27, which rounds to the $11.30 central target used here. The wide spread — from about $9.20 to $14.90 — underscores that the Street is not aligned on NOAH. Third-party aggregators also show a moving picture, with some reporting averages near $9.85 to $10.85 depending on which targets are included, so investors should treat any single "consensus" figure cautiously. No target should be read as a guarantee of where the stock will trade.
As of late October 2026, NOAH shares traded near $6.75, down from levels above $11 in early 2026 and near a 52-week low around $6.57. The stock's market capitalization is roughly $460 million, with a trailing P/E (price-to-earnings ratio) in the single digits and a forward dividend yield near 10%.
Reaching $11.30 from $6.75 implies about 67% appreciation — a very large move that would effectively retrace most of the stock's 2026 decline. That path would likely require a combination of stabilizing domestic revenue, sustained overseas growth, and a re-rating of the stock's compressed valuation. It would not be a modest step higher but a substantial recovery in investor confidence.
Several factors could underpin a rebound. The company ended 2025 with non-GAAP net profit up about 11% year over year and paid out effectively 100% of that profit as regular and special dividends, supporting a yield in the low double digits. Its balance sheet remains strong, with a net-cash position that provides a cushion. Overseas investment-product revenue has been growing quickly, and management is expanding international client acquisition. A compressed valuation means even modest earnings stability could, in theory, support a higher share price.
The obstacles are equally real. Fourth-quarter 2025 profit fell sharply on fair-value losses from equity affiliates and contingent litigation expenses, and JPMorgan has cautioned that 2026 revenue growth remains challenging. Domestic wealth-management demand is tied to China's property and capital-market cycles, which remain uncertain. Regulatory and legal overhangs add risk, and the stock's persistent slide toward its 52-week low signals weak investor sentiment that will take time to reverse. A high dividend yield alone has not, so far, been enough to arrest the decline.
NOAH sits just above its 52-week low near $6.57, with the $6.50 to $6.60 area acting as a key support zone. On the upside, the stock faces a prior trading shelf near $8.80, followed by the psychologically important $10 level, which would need to be cleared before the $11.30 target becomes reachable. The 52-week high around $12.45 marks a longer-term resistance reference. The current structure — a stock testing its lows — means a move toward the target would first require sustained buying pressure to break the downtrend.
Analyst price targets typically reflect a roughly 12-month research horizon, though the firms cited here do not publish identical timelines. Investors should watch the next earnings report and guidance, analyst revisions (particularly any update to Citi's above-consensus view), dividend declarations, and China macroeconomic and policy signals that affect wealth-management demand. The stock's next scheduled earnings were expected in late November 2026, making that a key catalyst for whether the recovery narrative gains traction.
Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs and generate Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. Traders can use these signals to discover new opportunities, monitor existing positions, and spot shifting trends more efficiently than manual screening alone. For a stock like NOAH, whose fortunes can turn quickly with earnings and China-related news, a systematic signal can help filter noise from meaningful change. Consider exploring the AI Daily Buy/Sell Signals to complement your own research.
Can NOAH reach $11.30? The figure is a calculated average of three recent analyst targets, and it sits roughly 67% above the current price — a very large move that would require a genuine turnaround in revenue and sentiment. The strongest supports are a double-digit dividend yield, a net-cash balance sheet, and accelerating overseas growth; the principal obstacles are weak domestic revenue, a legal overhang, and lingering China macro risk. Analyst views are sharply split, from UBS's cautious $9.20 to Citi's bullish $14.90, so the target represents a midpoint of disagreement rather than a consensus. What happens next will likely hinge on upcoming earnings, guidance, and any sign that domestic demand is stabilizing. No outcome is guaranteed, and the target should be viewed as a research reference, not a prediction.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor tells us that NOAH and SLRC have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NOAH and SLRC's prices will move in lockstep.
| Ticker / NAME | Correlation To NOAH | 1D Price Change % | ||
|---|---|---|---|---|
| NOAH | 100% | -0.63% | ||
| SLRC - NOAH | 31% Poorly correlated | -2.90% | ||
| TRIN - NOAH | 31% Poorly correlated | -1.49% | ||
| GSBD - NOAH | 30% Poorly correlated | -2.37% | ||
| BCSF - NOAH | 29% Poorly correlated | -2.76% | ||
| MAIN - NOAH | 29% Poorly correlated | -1.67% | ||
More | ||||